148 related articles for article (PubMed ID: 34003526)
61. Stability of αB-crystallin gene expression in canine mammary gland neoplasms. Should it be considered as circulating tumor cell genetic marker?
Chmielewska-Krzesińska M; Jakimiuk A; Wąsowicz K
Pol J Vet Sci; 2019 Sep; 22(3):523-529. PubMed ID: 31560457
[TBL] [Abstract][Full Text] [Related]
62. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
63. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
64. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
65. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
[TBL] [Abstract][Full Text] [Related]
66. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
67. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
68. A canine model of familial mammary gland neoplasia.
Schafer KA; Kelly G; Schrader R; Griffith WC; Muggenburg BA; Tierney LA; Lechner JF; Janovitz EB; Hahn FF
Vet Pathol; 1998 May; 35(3):168-77. PubMed ID: 9598580
[TBL] [Abstract][Full Text] [Related]
69. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
[TBL] [Abstract][Full Text] [Related]
70. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
71. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
Cassali GD; Gobbi H; Malm C; Schmitt FC
Cytopathology; 2007 Jun; 18(3):191-6. PubMed ID: 17573766
[TBL] [Abstract][Full Text] [Related]
73. Prolactin--to be reconsidered in canine mammary tumourigenesis?
Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
[TBL] [Abstract][Full Text] [Related]
74. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
75. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
77. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
78. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
79. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
Ferletta M; Grawé J; Hellmén E
Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
[TBL] [Abstract][Full Text] [Related]
80. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
